Klaria Pharma Holding AB (KLAR) — Cash Flow-to-Debt Ratio
Klaria Pharma Holding AB (KLAR) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of Skr-82.00K could theoretically repay 0% of its total liabilities (Skr50.62 Million) in one year. Check Klaria Pharma Holding AB (KLAR) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Klaria Pharma Holding AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Klaria Pharma Holding AB across 11 annual periods. Also explore KLAR current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Klaria Pharma Holding AB (2015–2025)
Year-by-year debt coverage analysis for Klaria Pharma Holding AB. For market capitalisation and broader financial context, see market value of Klaria Pharma Holding AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.78x | Skr-35.04 Million | Skr44.65 Million | ▼ -254.8% |
| 2024 | -0.22x | Skr-11.94 Million | Skr53.96 Million | ▲ +22.3% |
| 2023 | -0.28x | Skr-9.06 Million | Skr31.81 Million | ▲ +74.7% |
| 2022 | -1.13x | Skr-49.73 Million | Skr44.19 Million | ▼ -121.9% |
| 2021 | -0.51x | Skr-24.80 Million | Skr48.89 Million | ▲ +67.2% |
| 2020 | -1.55x | Skr-35.30 Million | Skr22.81 Million | ▼ -105.1% |
| 2019 | -0.75x | Skr-14.80 Million | Skr19.62 Million | ▲ +4.5% |
| 2018 | -0.79x | Skr-9.13 Million | Skr11.55 Million | ▲ +84.6% |
| 2017 | -5.13x | Skr-12.06 Million | Skr2.35 Million | ▲ +28.9% |
| 2016 | -7.22x | Skr-14.39 Million | Skr1.99 Million | ▼ -273.7% |
| 2015 | -1.93x | Skr-4.43 Million | Skr2.29 Million | — |